Maintaining our ISO/IEC 27001 certification—now upgraded to the 2022 standard—reflects our commitment to protecting sensitive data in life sciences. In an era where digital infrastructure is fundamental, robust security isn’t optional—it’s essential. cellportsoftware.com/news/cellport-…

What does seamless cell lab collaboration look like? Watch the video to discover how CellPort improves communication, enhances tracking, and simplifies reporting to drive better results. cellportsoftware.com/video/best-eln…

Designed for cell-based work, CellPort’s MBRs tie together protocols, materials, equipment, and people into a single, version-controlled system—capturing every detail needed to support consistent, traceable processes from research through GMP. cellportsoftware.com/features/maste…

CellPort is excited to share our bi-directional cell lineage tracing tool at this week’s ISCT 2025 conference! Designed for the EMA’s 2025 ATMP guidance, it delivers clear cell journey tracking, stronger traceability, and easier compliance. Let’s connect to explore more!

The EMA has issued clear guidance on traceability and material lineage for cell and gene therapy. CellPort was built to meet—and exceed—those standards with digital batch records, visual maps linking materials, and cross-site traceability. Learn more: cellportsoftware.com

Working with living cells means managing constant complexity. Our latest white paper explores why traditional systems fall short—and how purpose-built software like CellPort supports cell-based workflows from end to end. Download here: cellportsoftware.com/gated/the-case…

EMA’s new 2025 guidelines emphasize traceability and documentation in cell-based workflows. CellPort offers digital batch records, real-time tracking, flexible workflows, and audit-ready data to help labs stay compliant and efficient. Learn more: cellportsoftware.com/blog/cellport-…

EMA’s 2025 guidelines raise the bar for data integrity & traceability. Specialized software—like CellPort—offers the capabilities needed for audit readiness, traceability, and multi-site control. Download: cellportsoftware.com/gated/the-case…

We’re excited to be a part of the Philly Cell & Gene Therapy Conference — June 27–28 in King of Prussia! Don’t miss our talk: “From Bench to Batch: Operational Readiness for ATMPs in the New Regulatory Era”, June 27 at 11:45 AM in the Malvern Room. Visit our booth to connect!

Traditional systems often fall short for cell-based operations, where precision, traceability, and evolving protocols matter most. Specialized software—like CellPort—provides the tools teams need to stay confident and compliant. Download the white paper: cellportsoftware.com/gated/the-case…

Join CellPort at the 2025 Philly Cell & Gene Therapy Conference June 27–28. Don’t miss our CEO’s talk, “From Bench to Batch: Operational Readiness for ATMPs in the New Regulatory Era,” June 27 at 11:45 AM. Visit our booth to see how CellPort improves compliance and efficiency.

CellPort is at the Process Development for Cell Therapies Summit, July 16–17 in Boston. Join our CEO’s talk, “From Bench to Batch: Operational Readiness for ATMPs in the New Regulatory Era,” July 16 at 11:30 AM. Visit our booth to see how we support cell therapy development!

Cell-based workflows are complex. Managing them shouldn’t be. See how CellPort connects protocols, batch records, and materials—all in one traceable system. Watch the video: cellportsoftware.com/video/best-eln…

Cells are complex. Your workflows don’t have to be. CellPort brings structure that adapts—connecting inventory, protocols, scheduling, and teams in one intuitive platform. From research to GMP, get visibility, traceability, and control. cellportsoftware.com/blog/cellport-…

As regulations evolve, SaaS platforms like CellPort empower cell-based labs to keep documentation clear, ensure full traceability, and maintain compliance—helping teams work confidently every day. Read more: cellportsoftware.com/blog/navigatin…

New White Paper for Download! Learn how SaaS platforms unify complex ATMP processes—from cell lineage tracking and material traceability to digital batch records and equipment calibration—to help teams align with EMA 2025 guidelines. Download here: cellportsoftware.com/gated/leveragi…

EMA’s 2025 ATMP guidance calls for full traceability, process control, and validated documentation. Download our white paper to see how SaaS laboratory management systems enable cell lineage tracking, material oversight, and GMP-ready batch records. cellportsoftware.com/gated/leveragi…

We are excited to be part of Advanced Therapies Europe 2025, September 2–4 in Barcelona. Our CEO, Patrick Dentinger, will join the panel “Is decentralised manufacturing the way to cost effectiveness?” on September 3 at 11:00 AM in Theatre 2. We look forward to connecting!

CellPort is attending Advanced Therapies Europe, September 2–4 in Barcelona—bringing together ATMP and regenerative medicine leaders. On Sept 3 at 11:00 AM in Theatre 2, Patrick Dentinger joins “Is decentralised manufacturing the way to cost effectiveness?” See you in Barcelona.